324 filings
Page 3 of 17
8-K
qgmqq4
19 May 14
Auxilium Pharmaceuticals, Inc. Presents New Analyses of Xiaflex Peyronie’s Disease Data at Urology Meeting
12:00am
8-K
bn7 nw4wesnt
5 May 14
First Quarter 2014 Financial Results
12:00am
8-K
dr0kkiva 7vml
30 Apr 14
Company to Report Full 1Q 2014 Financial Results on Monday, May 5
12:00am
8-K
rxn9vi
28 Apr 14
Auxilium Pharmaceuticals, Inc. Announces Presentation of Data for Xiaflex at Urology Meeting
12:00am
8-K
8xs57hg93snbp3l
14 Apr 14
Auxilium and Sobi Announce Encore Presentation of Xiaflex/xiapex Data at European Association of Urology Congress
12:00am
8-K
lnln0shbu5 1r
7 Apr 14
Regulation FD Disclosure
12:00am
8-K
54tdc4z13ytb
28 Feb 14
Results of Operations and Financial Condition
12:00am
8-K
ctsw6cj9kv4
24 Feb 14
Departure of Directors or Certain Officers
12:00am
8-K
ebpp u9cl1dpqdg
24 Feb 14
Regulation FD Disclosure
12:00am
8-K
9kkc 0k3mvdoq2ud
27 Jan 14
Regulation FD Disclosure
12:00am
8-K
v470c8slr9nvwb6eww6
21 Jan 14
Regulation FD Disclosure
12:00am
8-K
bj9ejn
8 Jan 14
Data Show Recurrent Hand Contractures Treated Successfully in Nearly 90 Percent of Patients; Retreatment Shown to be Well-Tolerated
12:00am
8-K
vioxc70v
20 Dec 13
Auxilium Pharmaceuticals, Inc. Submits Application to the Fda Requesting Approval of Xiaflex® for Concurrent Treatment of Multiple Palpable Cords
12:00am
8-K
x62gwsos laonrd
19 Dec 13
Departure of Directors or Certain Officers
12:00am
8-K
9rqugex1d
13 Dec 13
Auxilium Pharmaceuticals, Inc. Announces First Patient
12:00am
8-K
5ehmfhzorfe20r6f
6 Dec 13
Auxilium Announces U.s. Food and Drug Administration Approval for Xiaflex® for the Treatment of Peyronie’s Disease
12:00am
8-K
n7k0 e4h4
4 Dec 13
Auxilium Pharmaceuticals, Inc. Announces Court Grants Upsher-smith Laboratories Motion for Summary Judgment
12:00am
8-K
76k7orjy1f12
25 Nov 13
Auxilium Pharmaceuticals Presented New Analyses of
12:00am
8-K
j1l4c7 u800i6i7kqtt
20 Nov 13
Xiaflex® at the Fall Scientific Meeting of the Sexual Medicine Society of North America
12:00am
8-K
s9c4 y6j9
18 Nov 13
Regulation FD Disclosure
12:00am